Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Anna Stankiewicz-Kranc, Wojciech Miltyk & Elzbieta Skrzydlewska. (2010) Comparison of influence of carmustine and new proline analog of nitrosourea on antioxidant system in breast carcinoma cells (MCF-7). Drug and Chemical Toxicology 33:1, pages 55-63.
Read now
Read now
Articles from other publishers (33)
Zahid H. Siddik. 2017. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
8
.
Pawel Wolski, Krzysztof Nieszporek & Tomasz Panczyk. (2022) Regulation of water access, storage, separation and release of drugs from the carbon nanotube functionalized by cytosine rich DNA fragments. Biomaterials Advances 137, pages 212835.
Crossref
Crossref
Shabir Ahmad GanaiShabir Ahmad Ganai. 2020. Histone Deacetylase Inhibitors in Combinatorial Anticancer Therapy. Histone Deacetylase Inhibitors in Combinatorial Anticancer Therapy
111
136
.
Saba Hadidi, Farshad Shiri & Mohammadsaleh Norouzibazaz. (2019) A DFT study of the degradation mechanism of anticancer drug carmustine in an aqueous medium. Structural Chemistry 30:4, pages 1315-1321.
Crossref
Crossref
Farshad Shiri, Mohammadsaleh Norouzibazaz, Ako Yari & Avat Taherpour. (2018) A DFT study of both the hydrolytic degradation and protonation of semustine in variation conditions of pH and interaction of drug with DNA nucleobases. Structural Chemistry 29:5, pages 1465-1474.
Crossref
Crossref
Pawel Wolski, Jolanta Narkiewicz-Michalek, Monika Panczyk, Giorgia Pastorin & Tomasz Panczyk. (2017) Molecular Dynamics Modeling of the Encapsulation and De-encapsulation of the Carmustine Anticancer Drug in the Inner Volume of a Carbon Nanotube. The Journal of Physical Chemistry C 121:34, pages 18922-18934.
Crossref
Crossref
Zahid H. Siddik. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
20
.
Thushara Chakkath, Sidonie Lavergne, Timothy Fan, David Bunick & Levent Dirikolu. (2015) Alkylation and Carbamylation Effects of Lomustine and Its Major Metabolites and MGMT Expression in Canine Cells. Veterinary Sciences 2:2, pages 52-68.
Crossref
Crossref
Amit S. Kalgutkar, Deepak Dalvie, R. Scott Obach & Dennis A. Smith. 2012. Reactive Drug Metabolites. Reactive Drug Metabolites
145
183
.
Jun Cao, Lijiao Zhao, Shubin Jin & Rugang Zhong. (2011)
Relationship between the molecular structure and the anticancer activity of
N
‐(2‐chloroethyl)‐
N
′‐cyclohexyl‐
N
‐nitrosoureas: A theoretical investigation
. International Journal of Quantum Chemistry 112:3, pages 747-758.
Crossref
Crossref
Laurent Gate & Kenneth D. Tew. 2011. Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures. Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures
61
85
.
Anna Stankiewicz‐Kranc, Anna Bielawska, Krzysztof Bielawski & Elzbieta Skrzydlewska. (2009) Proline Analogue of Nitrosourea as a New Cytotoxic Prodrug. Archiv der Pharmazie 342:11, pages 632-639.
Crossref
Crossref
Manny D. Bacolod, Randy Fehdrau, Stewart P. Johnson, Nancy S. Bullock, Darell D. Bigner, Michael Colvin & Henry S. Friedman. (2008) BCNU-sequestration by metallothioneins may contribute to resistance in a medulloblastoma cell line. Cancer Chemotherapy and Pharmacology 63:4, pages 753-758.
Crossref
Crossref
Anne-Celine Le Fevre, Eric Boitier, Jean-Pierre Marchandeau, Alain Sarasin & Veronique Thybaud. (2007) Characterization of DNA reactive and non-DNA reactive anticancer drugs by gene expression profiling. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 619:1-2, pages 16-29.
Crossref
Crossref
Lauren E. Frick, James C. Delaney, Cintyu Wong, Catherine L. Drennan & John M. Essigmann. (2007)
Alleviation of 1,
N
6
-ethanoadenine genotoxicity by the
Escherichia coli
adaptive response protein AlkB
. Proceedings of the National Academy of Sciences 104:3, pages 755-760.
Crossref
Crossref
Satoko Ishikawa & Masataka Mochizuki. (2007) Cross-linkable Nitrosamines with a Chloroalkyl Group as Candidates for Anticancer Lead Compounds. Genes and Environment 29:1, pages 1-10.
Crossref
Crossref
Zahid H. Siddik. 2005. The Cancer Handbook. The Cancer Handbook.
Manny D. Bacolod, Stewart P. Johnson, Anthony E. Pegg, M. Eileen Dolan, Robert C. Moschel, Nancy S. Bullock, Qingming Fang, O. Michael Colvin, Paul Modrich, Darell D. Bigner & Henry S. Friedman. (2004)
Brain tumor cell lines resistant to
O
6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have
O
6-alkylguanine-DNA alkyltransferase mutations
. Molecular Cancer Therapeutics 3:9, pages 1127-1135.
Crossref
Crossref
Rob PietersAlan Boddy. 2004. Paediatric Oncology, Third edition. Paediatric Oncology, Third edition
142
168
.
Satoko Ishikawa, Megumi Tajima & Masataka Mochizuki. (2004) Synthesis and properties of bifunctional chloroalkyl nitrosamines with an intercalating moiety. Bioorganic & Medicinal Chemistry 12:14, pages 3791-3796.
Crossref
Crossref
Alwin DR Huitema, Karen Doesburg Smits, Ron AA Math?t, Jan HM Schellens, Sjoerd Rodenhuis & Jos H Beijnen. (2000) The clinical pharmacology of alkylating agents in high-dose chemotherapy. Anti-Cancer Drugs 11:7, pages 515-533.
Crossref
Crossref
Sanjiv Gupta, Lynette K. Rogers, Sarah K. Taylor & Charles V. Smith. (1997) Inhibition of Carbamyl Phosphate Synthetase-I and Glutamine Synthetase by Hepatotoxic Doses of Acetaminophen in Mice. Toxicology and Applied Pharmacology 146:2, pages 317-327.
Crossref
Crossref
Emmanuelle Mounetou, Eric Debiton, Catherine Buchdahl, Daniel Gardette, Jean-Claude Gramain, Jean-Claude Maurizis, Annie Veyre & Jean-Claude Madelmont. (1997)
O
6
-(Alkyl/aralkyl)guanosine and 2‘-Deoxyguanosine Derivatives: Synthesis and Ability To Enhance Chloroethylnitrosourea Antitumor Action
. Journal of Medicinal Chemistry 40:18, pages 2902-2909.
Crossref
Crossref
M Eileen Dolan. (1997) Inhibition of DNA repair as a means of increasing the antitumor activity of DNA reactive agents. Advanced Drug Delivery Reviews 26:2-3, pages 105-118.
Crossref
Crossref
C. Thomas Gnewuch & George Sosnovsky. (1997)
A Critical Appraisal of the Evolution of
N
-Nitrosoureas as Anticancer Drugs
. Chemical Reviews 97:3, pages 829-1014.
Crossref
Crossref
Philip G. Penketh, Krishnamurthy Shyam & Alan C. Sartorelli. 1996. Drug Resistance. Drug Resistance
65
81
.
Emmanuelle Mounetou, Catherine Cussac, Frédérique Mathieu, Jean‐Claude Maurizis, Pierre Labarre, Marie‐France Moreau, Annie Veyre & Jean‐Claude Madelmont. (2006)
Synthesis of three no‐carrier‐added O
6
‐4‐[
125
I] iodobenzylguanosine derivatives, new reagents for the assay of O
6
‐alkylguanine‐DNA alkyltransferase activity
. Journal of Labelled Compounds and Radiopharmaceuticals 36:12, pages 1215-1225.
Crossref
Crossref
John K. Wiencke & Joseph Wiemels. (1995) Genotoxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Mutation Research/Reviews in Genetic Toxicology 339:2, pages 91-119.
Crossref
Crossref
Charles A. Koller, Carolyn C. Gorski, Robert S. Benjamin, Sewa S. Legha, Nicholas E. Papadopoulos & Carl Plager. (1994) A Phase I trial of weekly lomustine in patients with advanced cancer. Cancer 73:1, pages 236-239.
Crossref
Crossref
J. Ashby, E.W. Vogel, H. Tinwell, R.D. Callander & D.E.G. Shuker. (1993) Mutagenicity to Salmonella, Drosophila and the mouse bone marrow of the human antineoplastic agent fotemustine: Prediction of carcinogenic potency. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 286:1, pages 101-109.
Crossref
Crossref
B?atrice Gerard, S. Aamdal, S. Leyvraz, S.M. Lee, C. Lucas, J-P. Bizzari & M. D'Incalci. (1993) Activity and unexpected lung toxicity of the sequential administration of two alkylating agents?Dacarbazine and fotemustine?in patients with melanoma. European Journal of Cancer 29:5, pages 711-719.
Crossref
Crossref
B. Tranchand, C. Lucas, P. Biron, B. Giroux, B. Gordon, R. Richards, P. Solere, N. Roux, E. Evene, F. Mornex, M. Clavel & C. Ardiet. (1993) Phase I pharmacokinetics study of high-dose fotemustine and its metabolite 2-chloroethanol in patients with high-grade gliomas. Cancer Chemotherapy and Pharmacology 32:1, pages 46-52.
Crossref
Crossref
R. Fety, C. Lucas, P. Solere, V. Cour & J. Vignoud. (1992) Hepatic intra-arterial infusion of fotemustine: pharmacokinetics. Cancer Chemotherapy and Pharmacology 31:2, pages 118-122.
Crossref
Crossref